GlassScriptPhysician profile
Brian W Walter
NPI 1114394798
$11,492.58
in general payments reported to CMS, 2019-2025
46 companies · $3,667 in 2025
The $3,667 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $47.71 · 2021: $456 · 2022: $801 · 2023: $2,825 · 2024: $3,263 · 2025: $3,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,754.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,609.80 | 2022-2025 | Botox, Ubrelvy, Qulipta |
| Ucb, INC. | $1,337.76 | 2021-2025 | Briviact, Fintepla, Rystiggo |
| Neurocrine Biosciences, INC. | $890.54 | 2019-2025 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $868.01 | 2022-2025 | |
| Sk Life Science, INC. | $829.33 | 2022-2025 | Xcopri |
| Pfizer INC. | $808.54 | 2023-2025 | |
| Biogen, INC. | $319.09 | 2023-2025 | Vumerity, Tysabri, Avonex |
| Eisai INC. | $318.92 | 2022-2025 | |
| Lundbeck LLC | $304.89 | 2023-2025 | Vyepti |
| Lilly USA, LLC | $280.82 | 2022-2025 | Amyvid, Kisunla, Emgality |
| Harmony Biosciences LLC | $250.07 | 2022-2023 | Wakix |
| Argenx US, INC. | $231.50 | 2022-2025 | Vyvgart Hytrulo |
| Emd Serono, INC. | $219.56 | 2023-2025 | Mavenclad |
| Genentech USA, INC. | $201.46 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Acadia Pharmaceuticals INC | $189.69 | 2023-2025 | Nuplazid |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.